#  A Phenotypic Screening Technology Aimed at Drugging Undruggable Targets 

 



####  calendar\_today Date and Time 

 **February 23, 2016** 

 02:00PM - 03:00PM EST 

####  pin\_drop Location 

 **Dana-Farber Cancer Institute, Yawkey 308, 450 Brookline Avenue, Boston, MA**  



 

 



 

**Guest speaker:**  
***Chris Torrance, PhD***  
CEO and Co-founder  
PhoreMost, Ltd.  
Cambridge, UK



 

 

---

 Attachments- [  picture\_as\_pdf  ctorrance\_flyer.pdf ](/sites/g/files/omnuum10026/files/hsci/files/ctorrance_flyer.pdf)
 
---

 



 

 See also:- [ Biotechnology ](/event-disease-area/biotechnology)
- [ Cancer ](/event-disease-area/cancer)
- [ Dana-Farber Cancer Institute Seminars in Oncology ](/event-type/dana-farber-cancer-institute-seminars-oncology)
 
 

 Share on:- [     Facebook ](#)
- [     Twitter ](#)
- [     Linkedin ](#)
 


 Save: [ Add to calendar calendar\_today ](https://www.hsci.harvard.edu/node/649206/event-feed.ics)  Copy link link